HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion.

AbstractOBJECTIVE:
As prolactinomas fail to respond to dopamine agonist (DA) in 10-20% of cases, we hypothesized that somatostatin subtype 2 receptor (sst2) overexpression in DA-resistant prolactinomas may enhance suppression of prolactine (PRL) using chimeric agonist (dopastatin) that simultaneously binds sst2 and the dopamine subtype 2 receptor (D2DR).
DESIGN AND METHODS:
PRL suppression by octreotide, sst5 agonist, sst2-D2DR agonist (BIM-23A760 dopastatin) and cabergoline was assessed in primary cultures of seven DA-resistant prolactinomas overexpressing sst2.
RESULTS:
sst2 was effectively overexpressed via adenoviral expression in prolactinomas (38.1±7.4 vs. 0.1±0.1 copy/copy β-Gus) and induced octreotide sst2-mediated PRL suppression that remained lower than that induced by DA. BIM-23A760 inhibited PRL similarly to cabergoline both in the control and sst2-expressing cells. Antagonist experiments confirmed predominant dopaminergic effect in dopastatin activity.
CONCLUSION:
sst2 was successfully overexpressed in prolactinomas. However BIM-23A760 was unable to enhance PRL suppression underlining a predominant dopaminergic contribution in its action.
AuthorsThomas Cuny, Amira Mohamed, Thomas Graillon, Catherine Roche, Céline Defilles, Anne-Laure Germanetti, Bettina Couderc, Dominique Figarella-Branger, Alain Enjalbert, Anne Barlier, Alexandru Saveanu
JournalMolecular and cellular endocrinology (Mol Cell Endocrinol) Vol. 355 Issue 1 Pg. 106-13 (May 15 2012) ISSN: 1872-8057 [Electronic] Ireland
PMID22348806 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Dopamine Agonists
  • Ergolines
  • Receptors, Dopamine D2
  • Receptors, Somatostatin
  • Somatostatin
  • Prolactin
  • TBR-760
  • Cabergoline
  • Octreotide
  • Dopamine
Topics
  • Adenoviridae
  • Adolescent
  • Adult
  • Cabergoline
  • Dopamine (analogs & derivatives, metabolism, pharmacology)
  • Dopamine Agonists (pharmacology)
  • Ergolines (pharmacology)
  • Female
  • Genetic Vectors
  • Humans
  • Male
  • Octreotide (pharmacology)
  • Pituitary Neoplasms (drug therapy, metabolism, pathology)
  • Primary Cell Culture
  • Prolactin (antagonists & inhibitors, genetics)
  • Prolactinoma (drug therapy, metabolism, pathology)
  • Receptors, Dopamine D2 (metabolism)
  • Receptors, Somatostatin (genetics, metabolism)
  • Somatostatin (analogs & derivatives, pharmacology)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: